Customer Support: +919024236503

Need Help?

  • Share via whatsapp

GLIMITERIS TRIO 0.2: Benifits, Side Effects, Dosage.....

Jul 29, 2024

GLIMITERIS TRIO 0.2

Voglibose 0.2 mg, Glimepiride 3 mg & Metformin Hydrochloride 500 mg

GLIMITERIS TRIO 0.2 is a potent combination medication designed for managing type 2 diabetes. It combines Voglibose (0.2 mg), Glimepiride (3 mg), and Metformin Hydrochloride (500 mg) to provide a multi-faceted approach to controlling blood sugar levels.

Voglibose (0.2 mg)

Function: Voglibose is an alpha-glucosidase inhibitor that delays the absorption of carbohydrates from the intestines.
Benefits:

Helps in reducing postprandial blood sugar spikes, thus improving overall glycemic control.
Glimepiride (3 mg)

Function: Glimepiride is a sulfonylurea that stimulates the release of insulin from pancreatic beta cells.
Benefits: Enhances insulin secretion, thereby lowering blood glucose levels effectively.
Metformin Hydrochloride (500 mg)

Function: Metformin is a biguanide that reduces hepatic glucose production and increases insulin sensitivity.
Benefits: Improves insulin sensitivity and decreases glucose absorption from the intestines, making it a cornerstone of diabetes management.
Uses

Primary Use: Management of type 2 diabetes when diet, exercise, and other medications do not provide adequate glycemic control.
Additional Benefits: This combination therapy offers comprehensive blood sugar management by targeting multiple pathways of glucose regulation.
Dosage and Administration

Recommended Dose: One tablet taken before meals or as directed by a healthcare professional.
Administration: Should be taken with food to minimize gastrointestinal side effects and enhance efficacy.
Side Effects

Common: Gastrointestinal disturbances (such as nausea, diarrhea), hypoglycemia (low blood sugar), and dizziness.
Serious: Lactic acidosis (rare but serious metabolic condition), severe hypoglycemia, and allergic reactions. Regular monitoring and medical supervision are essential.
Conclusion

GLIMITERIS TRIO 0.2 provides an effective, multi-pronged approach to managing type 2 diabetes by combining Voglibose, Glimepiride, and Metformin. This combination medication helps in maintaining optimal blood sugar levels, reducing the risk of diabetes-related complications. Always follow your healthcare provider's instructions for dosage and monitoring to achieve the best outcomes.Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology. 

For further information 

Email: info@sterispharma.com / contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488  

BUY NOW

 

SHARE WITH

  • Share via whatsapp